"Prescription Fees" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.
Descriptor ID |
D011306
|
MeSH Number(s) |
N03.219.442.551.621
|
Concept/Terms |
Prescription Fees- Prescription Fees
- Dispensing Fees
- Dispensing Fee
- Fee, Dispensing
- Fees, Dispensing
- Fees, Prescription
- Fee, Prescription
- Prescription Fee
|
Below are MeSH descriptors whose meaning is more general than "Prescription Fees".
Below are MeSH descriptors whose meaning is more specific than "Prescription Fees".
This graph shows the total number of publications written about "Prescription Fees" by people in this website by year, and whether "Prescription Fees" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Fees" by people in Profiles.
-
Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM. Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions. Health Aff (Millwood). 2014 Aug; 33(8):1435-43.
-
Czechowski JL, Tjia J, Triller DM. Deeply discounted medications: Implications of generic prescription drug wars. J Am Pharm Assoc (2003). 2010 Nov-Dec; 50(6):752-7.
-
Briesacher B, Ross-Degnan D, Adams A, Wagner A, Gurwitz J, Soumerai S. A new measure of medication affordability. Soc Work Public Health. 2009 Nov-Dec; 24(6):600-12.
-
Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007 Jun; 22(6):864-71.
-
Tjia J, Schwartz JS. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus? J Am Geriatr Soc. 2006 Apr; 54(4):606-12.
-
Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith DH, Andrade SE, Soumerai SB. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005 Oct; 43(10):951-9.
-
Gurwitz JH, McLaughlin TJ, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Health Serv Res. 1995 Dec; 30(5):672-85.